Designing a Single Global Safety Governance Committee That Works Designing a Single Global Safety Governance Committee That Works Pharmacovigilance is a critical component of drug safety and risk management in the pharmaceutical industry. It involves the detection, assessment, analysis, and prevention of adverse effects or any other drug-related problems. With increasing globalization and the complexity of regulatory frameworks across different jurisdictions, establishing a Single Global Safety Governance Committee is vital for ensuring compliance with pharmacovigilance (PV) regulations and guidelines. This article aims to provide an in-depth understanding of the key elements required for creating an effective governance structure that aligns…

Balancing Local Regulatory Nuances with a Global PV Operating Model Balancing Local Regulatory Nuances with a Global PV Operating Model Pharmacovigilance (PV) is an essential component of drug safety, risk management, and regulatory compliance in the pharmaceutical industry. As companies expand their operations globally, navigating the intricate web of regional regulations becomes imperative. This article serves as a comprehensive regulatory explainer manual for professionals involved in pharmacovigilance, with a particular focus on aligning local regulatory nuances with a global operating model. Regulatory Affairs Context The field of Regulatory Affairs (RA) encompasses the responsibilities that organizations must adhere to in order…

Creating Practical Playbooks for FDA, EMA GVP and MHRA Inspections Creating Practical Playbooks for FDA, EMA GVP and MHRA Inspections Understanding the Regulatory Affairs Context The evolving landscape of pharmacovigilance (PV) compliance is critical for any pharmaceutical or biotech organization. Regulatory affairs (RA) professionals play a pivotal role in ensuring that the organizations comply with international GVP (Good Pharmacovigilance Practices) guidelines set forth by key regulatory bodies such as the FDA in the United States, EMA in Europe, and MHRA in the United Kingdom. Understanding how these regulatory bodies operate, their expectations, and the legal frameworks surrounding PV compliance is…

Signal, Periodic Report and RMP Requirements Across Major Agencies Signal, Periodic Report and RMP Requirements Across Major Agencies Context The field of pharmacovigilance is vital for ensuring drug safety and effective risk management. This article serves as a regulatory explainer manual on the various obligations that pharmaceutical and biotechnology companies must adhere to regarding pharmacovigilance systems across major agencies, including the FDA, EMA, and MHRA. Understanding the framework for signal detection, periodic reporting, and risk management plans (RMPs) is essential for compliance and product stewardship. Legal/Regulatory Basis The legal framework governing pharmacovigilance is defined through various regulations and guidelines applicable…

How ICH E2 Concepts Shape Safety Strategy from Development to LCM How ICH E2 Concepts Shape Safety Strategy from Development to LCM In the realm of pharmaceutical development, safety management is a crucial pillar that supports the overarching goal of delivering effective therapies to patients. Regulatory Affairs (RA) professionals play a vital role in ensuring that pharmacovigilance (PV) practices align with the various global frameworks established by regulatory authorities, including the FDA, EMA, MHRA, and the ICH guidelines. The ICH E2 series serves as a fundamental cornerstone for understanding how safety data is managed throughout the entire lifecycle of a…

Integrating Device and Vaccine PV Frameworks with Drug Safety Rules Integrating Device and Vaccine PV Frameworks with Drug Safety Rules Pharmacovigilance (PV) is an essential component of drug safety and risk management that ensures the evaluation of the safety of medicinal products including drugs, devices, and vaccines. This article provides a comprehensive overview of the relevant guidelines and regulatory frameworks governing PV practices in the UK, EU, and US. It addresses the integration of device and vaccine PV frameworks with existing drug safety rules, focusing on regulatory aspects, documentation, common deficiencies, and interaction with various teams within pharmaceutical companies. Regulatory…

Documentation Packages That Demonstrate PV Framework Compliance Documentation Packages That Demonstrate PV Framework Compliance The complexity of pharmacovigilance (PV) processes necessitates a robust understanding of regulatory frameworks that govern drug safety and risk management. Regulatory Affairs (RA) professionals, particularly those in CMC and Labelling teams within the pharmaceutical sector, bear the critical responsibility of ensuring that pharmacovigilance compliance aligns with the expectations of regulatory bodies such as the FDA, EMA, and MHRA. This article serves as a structured regulatory explainer manual on how to prepare documentation packages that demonstrate adherence to Global Pharmacovigilance (GVP) frameworks. Context Pharmacovigilance is essential for…

Global Partnerships and Licensing: Allocating PV Responsibilities Clearly Global Partnerships and Licensing: Allocating PV Responsibilities Clearly Context In the contemporary pharmaceutical landscape, where collaboration through partnerships and licensing agreements is increasingly commonplace, the need for a clear understanding of pharmacovigilance (PV) responsibilities has never been greater. Regulatory Affairs (RA) professionals are tasked with ensuring compliance with various regulations and guidelines, particularly those established by the FDA, EMA, MHRA, and ICH. This article serves as a comprehensive guide, outlining the key elements of PV responsibilities under different regulatory frameworks, assisting regulatory professionals and organizations in navigating the complexities associated with drug…

Training Busy Clinicians and MSLs on the Essentials of Global PV Rules Training Busy Clinicians and MSLs on the Essentials of Global PV Rules Context Pharmacovigilance (PV) is a critical component of drug safety and risk management, focusing on monitoring and assessing adverse effects of pharmaceutical products. The global regulatory framework for pharmacovigilance, particularly under the guidelines established by key regulatory bodies such as the FDA, EMA, and MHRA, requires that organizations implement robust systems to ensure patient safety. This article serves as a comprehensive guide for regulatory affairs professionals, clinical teams, and medical science liaisons (MSLs) to understand the…

KPIs That Show Whether Your PV Framework Is Really Working KPIs That Show Whether Your PV Framework Is Really Working In the dynamic landscape of pharmacovigilance (PV), maintaining robust compliance with global guidelines and regulations is non-negotiable. A well-structured PV framework is fundamental to ensuring that pharmaceutical companies can effectively monitor drug safety and manage risks associated with their products. This article provides a thorough exploration of the regulatory landscape surrounding pharmacovigilance, focusing on the key performance indicators (KPIs) that demonstrate the effectiveness of your PV framework, how to navigate regulatory expectations, and the importance of integrating compliance audits. Regulatory…